GSK Investigational Site

Bellevue, Washington 98007

0 studies enrolling now · 12 studies all time

What they study most

Acute Coronary Syndrome, Atherosclerosis, Churg-Strauss Syndrome, Common Cold, Cough, Depressive Disorder, Major, Diabetes Mellitus, Type 2, Eosinophilic Granulomatosis With Polyangiitis, Irritable Bowel Syndrome (IBS), Irritable Colon, Major Depressive Disorder (MDD), Pain

Studies at this site

• A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough — Completed
• A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain — Stopped early
• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 — Completed
• A Study In Patients With Type 2 Diabetes Mellitus — Completed
• To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold — Completed
• Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
• Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder — Completed
• Study Of GW679769 In Major Depressive Disorder — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed